THBS2, thrombospondin 2, 7058

N. diseases: 149; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE TSP-2 appears to be worth targeting for the prevention of bone metastasis in lung cancer. 31075265 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE TSP-2 expression was negatively associated with cancer cell proliferation and MMP-9 expression, whereas 4N1K-peptide was significantly associated with apoptosis, angiogenesis, and MMP-9 expression. 31092423 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE TSP-2 expression levels vary between different cancer types, and their role in tumor progression remains controversial. 30031810 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE Thrombospondin 2 (THBS2) expression and its prognostic value have been documented in several types of cancer. 30338785 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE The plasma concentration of THBS2 was able to discriminate resectable stage I cancer as readily as stage III/IV PDAC tumors. 28701476 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE Further study on the mechanism underlying the activity of THBS2 is warranted to have further implications for cancer diagnosis and treatment of pulmonary AC. 27513329 2016
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE Thrombospondin-2 (THBS2) and Thrombospondin-4 (THBS4) play an important role in cancer development and progression. 27160021 2016
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE Based on our findings, thrombospondin-1 (and not thrombospondin-2) may be considered as a target for antibody-based pharmacodelivery strategies, in consideration of its low expression in normal tissues and its upregulation in cancer. 24925479 2014